Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 195.83

-0.7%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TomOrt who wrote (26688)	11/27/1998 10:07:00 AM
From: Henry Niman	Read Replies (3) of 32384

Jim McCamnat was just on CNBC. Talked mostly in general terms and only smaller company mentioned was ISIP (CHIR was mentioned as a diversified Biotech and CNTO was mentioned as having some competition for Remicade for Crohn's disease from ISIP's product which was a couple of years away from approval). In lead in Joe Kernan mention Herceptin (GNE) and Enbrel (IMNX) and Mccamant indicated that the sectors progress had been steady, but price really hasn't moved much. Indicated that Biotech was like internet - with no limits and predicted a major price move soon. Joe Kernan mentioned prevention as a boon to quality of life and economy and McCamant mentioned drugs that allowed workers get back to work (example was Enbrel for RA). Mentioned that Gene Therapy was out of favor, so prices were low and also mentioned need for basket of stocks if 3rd tier companies were being considered.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next